# Magnetic Gastro-Ileal or Gastro-Jejunal Diversion Study ("MGI/MGJ Study")

> **NCT06073457** · NA · RECRUITING · sponsor: **GT Metabolic Solutions, Inc.** · enrollment: 35 (estimated)

## Conditions studied

- Obesity
- Type 2 Diabetes

## Interventions

- **DEVICE:** MagGJ System

## Key facts

- **NCT ID:** NCT06073457
- **Lead sponsor:** GT Metabolic Solutions, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-06
- **Primary completion:** 2026-03
- **Final completion:** 2027-01
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06073457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06073457, "Magnetic Gastro-Ileal or Gastro-Jejunal Diversion Study ("MGI/MGJ Study")". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT06073457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*